Last reviewed · How we verify
NCT03487523
Health Message Framing to Improve Uptake of Bowel Cancer Screening
NA trial testing Text Message in Colorectal Cancer in 1,600 participants. Status unknown.
21 December 2018
Quick facts
| Lead sponsor | National Heatlh Service Ayrshire and Arran |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 1,600 |
| Start date | 21 June 2018 |
| Primary completion | 21 December 2018 |
| Estimated completion | 31 January 2019 |
Drugs / interventions tested
- Text Message — full drug profile →
Conditions studied
- Colorectal Cancer — all drugs for Colorectal Cancer →
Sponsor
National Heatlh Service Ayrshire and Arran
Who can join
55 and older, any sex, with Colorectal Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The objective of this research is to investigate whether a text message (SMS message) prompting participation in the UK national bowel cancer screening programme improves uptake for those who have not responded to the test. The secondary objective is to investigate whether the framing/phrasing of the text message improves participation , whether by stating the benefits of uptake or alternatively by stating the costs of non-uptake.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03487523
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Text Message
Trials testing the same drug.
- NCT06909500 — A Digital Intervention (ACT on Vaping App) for Vaping Cessation in Young Adult E-Cigarette Users · NA · not yet recruiting
- NCT05503186 — Text Intervention to Facilitate Secure Storage and Disposal of Prescription Opioids · NA · completed
- NCT05897242 — A Smartphone Application (ACT on Vaping) for Vaping Cessation in Young Adults · NA · completed
- NCT04719390 — BabySTEPs: Supportive Texts to Empower Parents · NA · completed
- NCT04029883 — Behavioral Economics to Improve Antihypertensive Therapy Adherence · NA · completed
Other recruiting trials for Colorectal Cancer
Currently open trials in the same condition.
- NCT07152821 — Botensilimab + Balstilimab vs Best Supportive Care as Therapy in Chemo-refractory, Unresectable, Colorectal Adenocarcino · Phase 3 · recruiting
- NCT07353645 — KRAS Neoantigen Nanovaccine as Adjuvant Therapy for Colorectal Cancer/Pancreatic Cancer · Phase 1, PHASE2 · recruiting
- NCT07432633 — [18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications · Phase 1, PHASE2 · recruiting
- NCT07523919 — Functional and Respiratory Determinants of Long-Term Colorectal Cancer Outcomes · recruiting
- NCT07529301 — Functional and Respiratory Predictors of Early Postoperative Outcomes · recruiting
Other National Heatlh Service Ayrshire and Arran trials
Trials by the same sponsor.
- NCT05020691 — NIV in Covid-19 Respiratory Failure · terminated
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03487523 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by National Heatlh Service Ayrshire and Arran
- Last refreshed: 4 April 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03487523.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing